Recently Viewed
Clear All

Genomic Valley Biotech Ltd.

factsheet Stock Card watchlist-stock-modal share-fund-plan-icon
  • Value Research Rating market-capitalisation-info
    UnratedSee Why?
  • Market Capitalisation market-capitalisation-info ₹18 Cr
  • Price to Earnings Ratio price-to-earning 140.98
  • 12 Month Earnings monthly-earning ₹0 Cr

Genomic Valley Biotech Ltd. Share Price

BSE

₹59.99

As on 14-Aug-2024 10:16 IST

up-down-arrow ₹-0.01 • -0.02%

  • Prev Close info

    ₹60.00

  • Day's Openinfo

    ₹59.99

  • Today's Highinfo

    ₹59.99

  • Today's Lowinfo

    ₹59.99

  • Today's Volumeinfo

    120

  • 52 Week rangeinfo

    ₹21.00 - 64.20

Stock Range

Today’s Range
Low 59.99 High: 59.99
52 Week Range
Low 21.00 High: 64.20
Liquidity
Low High

Genomic Valley Biotech Ltd. Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Genomic Biotech
60.23 26.56 94.14 175.69 -- -- --
BSE Healthcare
29.84 6.68 16.72 46.55 16.54 26.64 12.71
BSE Small Cap
23.89 -2.12 16.73 49.81 26.12 33.39 18.47
As on 14-Aug-2024
The underlying data is unavailable.

Valuation Score
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

More Details about Key Ratiosarrow

Genomic Valley Biotech Ltd. Peer Comparison

search
search
search
search
    See More Peer Comparisonsarrow

    Valuation Chart of Genomic Valley Biotech Ltd.

        Financials

        See More Financial Detailsarrow

        Shareholding Pattern

        See More Details of Holdingsarrow

        News & Analysis of Genomic Valley Biotech Ltd.

        No Review & Analysis are available.

        See More Details arrow

        Other details of Genomic Valley Biotech Ltd.

        Incorporated

        1994

        Chairman

        --

        Managing Director

        Yogesh Agrawal

        Headquarters

        Jhajjar Dist, Haryana

        Website

        www.genomicvalley.com
        More Detailsarrow

        Value Research Ratings

        Our rating system has guided millions of investors in the past 20 years.

        Top Rated Stocks

        All stocks with 5-star Value Research Ratings

        Top Rated Stocks Icon

        High Quality Small Caps

        Small-cap stocks rated high on quality score

        High Quality Small Caps Icon

        High Growth Large Caps

        Large-cap stocks with a high growth score

        High Growth Large Caps Icon

        Top Value Mid Caps

        Mid-cap stocks rated high on valuation score

        Top Value Mid Caps Icon

        Top Rated Banks

        Banks that rate high on Value Research Stock Ratings

        Top Rated Banks Icon
        Explore Screeners

        FAQs for Genomic Valley Biotech Ltd.

        The total asset value of Genomic Valley Biotech Ltd stood at ₹ 4 Cr as on 30-Jun-24

        The share price of Genomic Valley Biotech Ltd is ₹59.99 (BSE) as of 14-Aug-2024 10:16 IST. Genomic Valley Biotech Ltd has given a return of 175.69% in the last 1 years.

        Genomic Valley Biotech Ltd has a market capitalisation of ₹ 18 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Genomic Valley Biotech Ltd is 4.99 times as on 13-Aug-2024, a 389% premium to its peers’ median range of 1.02 times.

        The P/E ratio of Genomic Valley Biotech Ltd is 140.98 times as on 13-Aug-2024, a 81% discount to its peers’ median range of 723.80 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Genomic Valley Biotech Ltd and enter the required number of quantities and click on buy to purchase the shares of Genomic Valley Biotech Ltd.

        Wholesale of agricultural raw materials and live animals

        The promoters of Genomic Valley Biotech Ltd are Yogesh Agrawal and Parul Agrawal. They collectively own 64.07 per cent of the total equity. The chairman of the company is

        There is no promoter pledging in Genomic Valley Biotech Ltd.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        Lyka Labs
        452
        Vivo Bio Tech
        58
        Lyka Labs
        452
        Vivo Bio Tech
        58
        Genomic Valley Biotech Ltd. Ratios
        Return on equity(%)
        3.65
        Operating margin(%)
        49.62
        Net Margin(%)
        49.62
        Dividend yield(%)
        0

        Yes, TTM profit after tax of Genomic Valley Biotech Ltd was ₹0 Cr.

        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹18.33 Cr
        • Revenue (TTM)revenue-information ₹0.26 Cr
        • Earnings (TTM) earning-information ₹0.13 Cr
        • Cash date-information ₹0.01 Cr
        • Total Debt info ₹0.00 Cr
        • Promoters' ownership promoters_ownership 64.14%
        • Liquidity liquidity Moderate
        • 52 Week range week-range ₹21.00 - 64.20
        • Face value face-value ₹10.00
        • Shares outstanding share-outstanding 30,54,500
        • 10 Years Aggregate:

          CFO: ₹-1.39 Cr

          EBITDA: ₹0.86 Cr

          Net Profit: ₹0.22 Cr

        About The Company

        • Incorporated 1994
        • Chairman --
        • Managing Director Yogesh Agrawal
        • Listing key-listing BSE: 539206
        • Country India
        • Headquarters headquarters Jhajjar Dist, Haryana
        • Website website www.genomicvalley.com
        • Business

          Wholesale of agricultural raw materials and live animals

        Stocks stock name Genomic Valley Biotech Ltd.